SCHEMBL10265117

SCHEMBL10265117

COC(=O)c1sc(C#CC(C)(C)OC)cc1N(CC(=O)N1CCOCC1)C(=O)C1CCCCC1

nearest known ligand 0.63

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CYP2E1 P05181 1/20 0.63
▸ NR1I2 O75469 2/20 0.36
▸ NR1H4 Q96RI1 2/20 0.36
▸ CTSL P07711 3/20 0.32
▸ CTSS P25774 3/20 0.32
▸ CTSD P07339 2/20 0.32
▸ CTSB P07858 2/20 0.32
▸ EPHX2 P34913 1/20 0.32
▸ ALDH1A1 P00352 3/20 0.31
▸ GLA P06280 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ MCOLN3 Q8TDD5 1/20 0.31
▸ APOBEC3G Q9HC16 1/20 0.30
▸ PDE4D Q08499 1/20 0.30
▸ CTSK P43235 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL325918 0.93 CYP2E1 (0.73) CYP2E1NR1I2CTSLCTSSCTSD
SCHEMBL325919 0.93 CYP2E1 (0.73) CYP2E1NR1I2CTSLCTSSCTSD
SCHEMBL10264956 0.86 CYP2E1 (0.57) CYP2E1NR1I2NR1H4CTSSEPHX2
SCHEMBL323600 0.86 CYP2E1 (0.85) CYP2E1NR1I2CTSLCTSSCTSD
SCHEMBL323601 0.86 CYP2E1 (0.85) CYP2E1NR1I2CTSLCTSSCTSD
SCHEMBL10265012 0.84 CYP2E1 (0.51) CYP2E1NR1H4CTSLCTSSCTSD
SCHEMBL15132465 0.82 CYP2E1 (0.64) CYP2E1NR1I2CTSLCTSSCTSD
SCHEMBL15130892 0.82 CYP2E1 (0.64) CYP2E1NR1I2CTSLCTSSCTSD
SCHEMBL10268712 0.82 CYP2E1 (0.64) CYP2E1NR1I2CTSLCTSSCTSD
SCHEMBL319041 0.81 CYP2E1 (0.67) CYP2E1NR1I2EPHX2ALDH1A1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012006055-A2 COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-01-12 — — WO disclosed
Send feedback